Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IOTA Pharmaceuticals
Cambridge, Cambridgeshire, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
IOTA Pharmaceuticals is an early-stage drug discovery and discovery-services company using target-based and fragment-based approaches to generate small-molecule leads against oncology and neglected parasitic disease targets; it does not appear to have disclosed clinical-stage assets and mainly operates as a preclinical research and service partner.[1][2][3][5]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
02
Partnerships
Eurostars KINOMED programme – combination therapies based on fragment-based protein kinase drug design[1]FP7 PDE4NPD consortium – parasite-specific phosphodiesterase inhibitors for neglected parasitic diseases[1]GENIALG project – drug discovery expertise and seaweed biorefinery R&D role[1]FRAGNET (EU H2020 Marie Curie Actions) fragment-based discovery network[3]
Beyond the preview
Go deeper on IOTA Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IOTA Pharmaceuticals.